Benzinga's Top #PreMarket Losers By: Benzinga via Benzinga February 09, 2015 at 08:14 AM EST Regulus Therapeutics Inc.(NASDAQ: RGLS) shares dropped 12.57% to $14.74 in pre-market trading after the company reported top-line ... Read More >> Related Stocks: Himax Technologies ADR Regulus Therapeutics Shire Plc Ads